University College London Hospitals NHS Foundation Trust

Our latest #UCLHMagazine is out now! Read about how pioneering work by UCLH consultant surgeon Professor Peter Andrews is helping long #COVID patients to regain their sense of smell. Grab a copy at any of our hospital sites or read online: https://buff.ly/cYIlOlm #magazine #healthcare #nhs #nhsstaff #uclh #health #hospital

♻️We have updated our Green Plan, Care Without Carbon, building on our #netzero strategy first launched in 2023. The plan reflects our ambition to create an environment where #sustainability is embedded in everything we do, for the wellbeing of our patients, staff and wider community. Elliott Westhoff, head of sustainability said: “This updated Green Plan is an opportunity to celebrate our successes and be clear about the measurable actions we’ll take next. "Crucially, it shows how sustainability delivers a triple win for us – lowering emissions, improving patient outcomes, and freeing up savings that can be reinvested in better care.” Learn more: https://buff.ly/iuEbLF1 #greenerNHS #nhs #healthcare

A new Neuralink study aiming to help people with paralysis to control devices and communicate more independently opens today. Read more about eligibility conditions like spinal cord injury or motor neurone disease: https://buff.ly/hG8Nmau

UCLH has recruited the first participant in the UK to a study looking at a new investigational drug for patients with a condition affecting the blood vessels in the brain called cerebral amyloid angiopathy (CAA).   Professor David Werring, consultant neurologist at The National Hospital for Neurology and Neurosurgery, Queen Square and Professor of Clinical Neurology at the UCL Stroke Research Centre said, “This is an exciting milestone for cerebral amyloid angiopathy (CAA) treatment in the UK, as it is the first time we have been able to offer the chance to participate in a trial of a drug that might directly influence the biology of amyloid protein production and accumulation to reduce the risk of intracranial hemorrhage.”   Find out more: https://buff.ly/Yuly8jI NIHR University College London Hospitals Biomedical Research Centre

“I'm very happy to have enjoyed the career I have, and I hope I'll still be here for a while to come.” This year, Carole Jordan, senior staff nurse in Endoscopy, is celebrating an incredible milestone – 60 years’ service as a nurse. Carole’s nursing career began in 1965, following training at what is now the Royal London Hospital. “I managed to train in both adult and paediatric care, which is unusual now. This meant I was able to move around early in my career, experiencing different hospitals and environments. I’ve been incredibly lucky to have such variety as a nurse, and to have supported and cared for so many different people.” Over Carole’s career, she’s never stopped learning, completing a nursing degree at King’s College and a postgraduate diploma in medical ethics. She continues through sheer passion for her patients. “I still love to be with the patients, even as a sister. I always feel if you are hands-on as a sister, you can see and feel what is going on." Read more here: https://buff.ly/5nIMmNT #oneteam💙 #healthcare #nhs #nurse

Doctors at UCLH and UCL have developed a digital decision-making aid, MENO.pause, to help clinicians manage #menopause symptoms in the best way for individual patients’ health conditions. MENO.pause also supports women who have complex health conditions, providing treatment options for those going through cancer treatment, which may cause early menopause, and for women who have a genetic variation which puts them at higher risk of cancer. Dr Shibani Nicum, honorary medical oncologist at UCLH, and founder and project lead for MENO.pause, said: “We are committed to providing the highest quality menopause care across the country and are delighted to have launched the MENO.pause App, which transforms national menopause guidance into clear, step-by-step decision-making support. “With up to 13 million women currently going through menopause in the UK and too few trained specialists, the MENO.pause app helps to meet the need for improved access to high quality advice by providing information on a wide range of treatments in one place." Read more here: https://buff.ly/g26zomQ #nhs #healthcare #uclh

In 2022, Ben (pictured) was the first patient in the world to undertake a novel immunotherapy trial to treat #glioblastoma, an aggressive form of brain cancer, prior to standard treatment. Today, Ben is doing well with no active tumour present on scans. UCLH is now recruiting patients with newly diagnosed glioblastoma to get involved with the same trial. Ben said: “I am delighted that this new trial, with the same immunotherapy drug I received, is going ahead and others will have the opportunity to take part. "It will give people newly diagnosed with glioblastoma some hope.” Read more: https://buff.ly/OX1B6YN #nhs #healthcare #cancer

Last week the Lung Cancer Screening Team from University College London Hospitals NHS Foundation Trust were at Chapel Market in Islington raising awareness in the community about lung health checks. We want to thank Cllr Jason Jackson, the Mayor of Islington, who popped down to meet the team and show support. The team was joined by Breathe giving smoking cessation advice and Healthwatch Islington offering free blood pressure checks. It was a fantastic collaborative effort and great opportunity to connect with local stall holders and the general public. Thanks to everyone who stopped to talk to us and find out more. Lung Cancer Screening is offered to anyone aged 55-74, who smokes or used to smoke, and lives in Barnet, Camden, Enfield, Haringey or Islington. If you, or someone you know, meet this criteria, find out more at www.lungchecklondon.org #LungCancer, #LungCancerScreening, #LungHealthCheck #EarlyDiagnosis Pictured left to right: Amy Hemmington (NCL Lung Cancer Screening Health Promotion Lead), Cllr Jason Jackson (Mayor of Islington), Jay Uddin (Breathe Trainer and Volunteer Lead), Gulum Sener (Healthwatch Islington Volunteer Manager).

Gastric Alimetry Enters the NHS at UCLH 💙 🏥 🇬🇧 We’re proud to share that University College London Hospitals NHS Foundation Trust (UCLH) has officially adopted Gastric Alimetry into routine NHS clinical care, following a successful pilot and business case approval. This milestone marks our first NHS clinical activation! It is a meaningful step in delivering innovative, non-invasive diagnostics to patients with chronic gastric symptoms across the United Kingdom. A heartfelt thank you to the fantastic team at UCLH, including Dr Asma Fikree, Dr Natalia Zarate-Lopez, Dr Konstantinos Fragkos, Dylan Smiley , Holly Mills and James Endersby, whose leadership and commitment made this possible. With UCLH now live, we’re excited to support other NHS sites exploring clinical implementation of Gastric Alimetry.

New research shows that a standard imaging tool used in cancer can be safely used in selected pregnant women with breast cancer, offering crucial information to guide treatment decisions without compromising foetal safety. The analysis was led by Dr Karen DeSouza, Consultant Medical Oncologist, and Dr Stefan Vöö, Consultant Nuclear Medicine Physician, who both work across UCLH and Whittington Health. Dr DeSouza said: “For carefully selected patients, PET imaging can provide vital staging information that directly influences treatment, including the timing of surgery and administration of chemotherapy. In this small series, we saw no short-term harm to the foetus and meaningful clinical benefit to the mother. These findings offer much-needed reassurance to both clinicians and patients navigating cancer care during pregnancy.” Dr Vöö said: “By significantly reducing the dose and using optimised imaging protocols, we were able to keep foetal radiation exposure well below levels associated with any known risk. These results show that PET imaging, when used judiciously, can be both safe and clinically impactful during pregnancy.” Find out more: https://buff.ly/1Hdsped